{
    "clinical_study": {
        "@rank": "161554", 
        "arm_group": {
            "arm_group_label": "Vancomycin concentrations", 
            "arm_group_type": "Other", 
            "description": "Vancomycin concentrations will be collected in subjects who are to undergo cardiac surgery with cardiopulmonary bypass and modified ultrafiltration."
        }, 
        "brief_summary": {
            "textblock": "Antibiotics are routinely used to prevent surgical wound infection. Vancomycin is a widely\n      used antibiotic for surgery in patients with an allergy to penicillin. During cardiac\n      surgery, cardiopulmonary bypass (CPB) and modified ultrafiltration (MUF) are routinely used\n      and can lower the level of the antibiotic. The purpose of this study is to quantify the\n      change in  plasma  vancomycin concentration associated with cardiopulmonary bypass and\n      modified ultrafiltration."
        }, 
        "brief_title": "The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Vancomycin Concentration", 
        "detailed_description": {
            "textblock": "Subjects having cardiac surgery in which they will be on a heart-lung machine and will\n      receive the antibiotic vancomycin, will be able to participate.\n\n      During the surgery once receiving vancomycin, several samples of blood will be collected to\n      test the vancomycin levels.  Participation will be complete once the cardiac surgery has\n      been finished."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Scheduled to undergo cardiac surgery with cardiopulmonary bypass and    modified\n             ultrafiltration\n\n          -  age greater than 18 years old\n\n          -  penicillin allergy or in-hospital stay greater than 24 hours\n\n          -  normal renal function\n\n          -  normal liver function\n\n          -  absence of clinical and laboratory signs of infection\n\n        Exclusion Criteria:\n\n          -  vancomycin allergy\n\n          -  pregnancy\n\n          -  impaired renal function\n\n          -  impaired liver function\n\n          -  morbid obesity\n\n          -  active infections\n\n          -  Jehovah's Witness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02051595", 
            "org_study_id": "201300857"
        }, 
        "intervention": {
            "arm_group_label": "Vancomycin concentrations", 
            "description": "Vancomycin concentrations will be collected in subjects who are to undergo cardiac surgery with cardiopulmonary bypass and modified ultrafiltration.", 
            "intervention_name": "Vancomycin concentrations", 
            "intervention_type": "Other", 
            "other_name": [
                "pharmacodynamics", 
                "vancomycin monitoring", 
                "serum concentrations of vancomycin"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Vancomycin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "heart lung machine", 
            "blood pump", 
            "cardiac surgery", 
            "cardiopulmonary bypass", 
            "circulation"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "email": "jwishin@anest.ufl.edu", 
                "last_name": "Judith Wishin", 
                "phone": "352-494-3165"
            }, 
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32610"
                }, 
                "name": "UF Health"
            }, 
            "investigator": {
                "last_name": "Ettore Crimi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery", 
        "overall_contact": {
            "email": "jwishin@anest.ufl.edu", 
            "last_name": "Judith M. Wishin, BSN", 
            "phone": "352-494-3165"
        }, 
        "overall_contact_backup": {
            "email": "ecrimi@anest.ufl.edu", 
            "last_name": "Ettore Crimi, MD", 
            "phone": "617-697-2861"
        }, 
        "overall_official": {
            "affiliation": "University of Florida", 
            "last_name": "Ettore Crimi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Blood samples to monitor the vancomycin concentration will be collected at several time points during surgery.", 
            "measure": "Circulating vancomycin concentration", 
            "safety_issue": "No", 
            "time_frame": "Study participants will be in this study until the end of their surgery."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02051595"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}